STEPHANIE METCALF: Open Payments
NPI 1619297801 · CLARKSVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 13 payments from 6 companies in 2025. Trend: 2023 $309 · 2024 $297 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $50 |
| ABBVIE INC. | 2 | $50 |
| Antares Pharma, Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Ozempic, XYOSTED, MOUNJARO, REXULTI, UBRELVY, QULIPTA, CAPLYTA.
Industry payments across AR — which companies pay providers there.
